WB
www.barabio.co.kr
The startup develops next-generation anticancer drugs utilizing metabolic disease and muscle-related biomarkers, alongside diagnostic kits to enhance patient care. By establishing a digital healthcare platform, the company aims to provide targeted therapies that address the limitations of current cancer treatments, improving outcomes for patients.
Traction –/10
HQ unknown
- Biotechnology
- Digital Health
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops next-generation anticancer drugs utilizing metabolic disease and muscle-related biomarkers, alongside diagnostic kits to enhance patient care. By establishing a digital healthcare platform, the company aims to provide targeted therapies that address the limitations of current cancer treatments, improving outcomes for patients.